Peptide Vaccination in Treating Patients With Esophageal Cancer
NCT00682227
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
BIOLOGICAL:
TTK, LY6K, and IMP-3 peptides
Sponsor
University of Yamanashi
Collaborators
[object Object]